BioSpace News Archive

Ember Technologies, Inc. (Ember®), the global design-led temperature control brand and maker of the award-winning temperature control mug, today announced the spinout of its new healthcare vertical, Ember LifeSciences.

Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced today that the second quarter of 2022 was the best in company history.

The latest market analysis report published by Reports and Data, titled ‘Global Lipodystrophy Market – Forecast to 2030,’ thoroughly examines the Lipodystrophy industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Metastatic Castration-Resistant Prostate Cancer Market – Forecast to 2030,’ thoroughly examines the Metastatic Castration-Resistant Prostate Cancer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global SGLT-2 Inhibitors Market – Forecast to 2030,’ thoroughly examines the SGLT-2 Inhibitors industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Nail Disease Market – Forecast to 2030,’ thoroughly examines the Nail Disease industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Wegeners Granulomatosis Market – Forecast to 2030,’ thoroughly examines the Wegeners Granulomatosis industry to provide essential data & information for the targeted readers.

Zavation Medical Products, an innovative designer and manufacturer of spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the results of its novel LABYRINTH™ technology in an In-Vitro and In-Vivo research project.

CaliberMRI, an industry leader in standardization of Magnetic Resonance Imaging, has been awarded a grant from the Bill & Melinda Gates Foundation to improve repeatability and reproducibility of diagnostic imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia.

Catalyst Biosciences, Inc. announced that it has received a notice from JDS1, LLC that JDS1 has withdrawn the nominations of Shelly C. Lombard, Matthew Stecker, and Igor Volshteyn for election to the Catalyst Board of Directors at the Catalyst 2022 annual meeting of stockholders, which is scheduled for August 15, 2022.